Skip to main content
search
 

21 CFR 99 - DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES

Title 21 published on 2011-04-01

no entries appear in the Federal Register after this date.

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.


United States Code

21 USC 321 - Definitions; generally

21 USC 331 - Prohibited acts

21 USC 351 - Adulterated drugs and devices

21 USC 352 - Misbranded drugs and devices

21 USC 355 - New drugs

21 USC 360 - Registration of producers of drugs or devices

21 USC 360aa - Recommendations for investigations of drugs for rare diseases or conditions

21 USC § 360aaa to 360aaa–6 - Omitted

21 USC 360bb - Designation of drugs for rare diseases or conditions

21 USC 360c - Classification of devices intended for human use

21 USC 360cc - Protection for drugs for rare diseases or conditions

21 USC 360dd - Open protocols for investigations of drugs for rare diseases or conditions

21 USC 360e - Premarket approval

21 USC 360ee - Grants and contracts for development of drugs for rare diseases and conditions

21 USC 360hh - Definitions

21 USC 360ii - Program of control

21 USC 360jj - Studies by Secretary

21 USC 360kk - Performance standards for electronic products

21 USC § -

21 USC 360mm - Imports

21 USC 360nn - Inspection, records, and reports

21 USC § -

21 USC 360pp - Enforcement

21 USC 360qq - Repealed.

21 USC 360rr - Federal-State cooperation

21 USC 360ss - State standards

21 USC 374 - Inspection